Randy Goodman, Ph.D. has been named manager of Scientia Advisors' Pricing and Market Access Group. Scientia Advisors is a global management consulting firm specializing in strategy, operations and pricing/reimbursement for major and emerging companies in healthcare, life sciences, pharma, biotechnology, and health IT. The Pricing and Market Access Group helps companies determine how best to introduce and develop pricing structures, and obtain reimbursement from third-party payers.
“Dr. Goodman comes to Scientia with a wealth of experience in the managed care, medical device, and biotech industries,” said Harry Glorikian, Scientia Advisors’ founder and managing partner. “He has directed pricing, reimbursement and managed markets strategies for a variety of US and global healthcare and device companies and has served as a consultant to the White House on health reform. We are delighted to welcome him to our firm.”
Prior to joining Scientia, Dr. Goodman was consultant/director of health economics, reimbursement, managed markets and government relations for Welldoc, Inc., a provider of mobile health diabetes solutions in the U.S. Previously, he served in a similar capacity for medical device/equipment companies ImpediMed, Access Mediquip, and Hoveround. At various times, he has overseen and managed strategic development, clinical reimbursement policy, regulation and financial analysis, business development, sales and marketing, among other duties.
Dr. Goodman also served as a Health Care Reform Policy Consultant to the White House Office of Health Reform in 2009 and 2010 and counseled and collaborated with the White House and Congress on health reform proposals in 1992 and 1993.